<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://www.cuttingedgeinfo.com/wp/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/3.2.1" -->
<!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.2.6" -->
<!-- generated-on="February 21, 2012 9:27 pm" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://www.cuttingedgeinfo.com/</loc>
		<lastmod>2012-02-15T20:33:00+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/patient-adherence-wireless-tech/</loc>
		<lastmod>2012-02-21T21:26:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/communicating-innovation-health-economics-analysis/</loc>
		<lastmod>2012-02-21T20:10:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/epharma-summit-day-two/</loc>
		<lastmod>2012-02-21T20:09:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/epharma-summit-day-three/</loc>
		<lastmod>2012-02-21T20:05:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/epharma-summit-day-one/</loc>
		<lastmod>2012-02-21T19:41:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/companion-diagnostics-personalized-medicine/</loc>
		<lastmod>2012-02-20T16:09:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/-0001/drug-pricing-teams-phase-ii-development/</loc>
		<lastmod>2012-02-20T14:26:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/health-economics-and-outcomes-pricing-phase/</loc>
		<lastmod>2012-02-20T14:11:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/supporting-clinical-development-health-economics/</loc>
		<lastmod>2012-02-20T14:03:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/fair-market-benchmarking-service-kol-compensation-data-100-countries/</loc>
		<lastmod>2012-02-16T22:37:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/culture-emerging-markets-clinical-trials/</loc>
		<lastmod>2012-02-16T21:47:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/brilinta-trajenta-germany-new-pricing-law/</loc>
		<lastmod>2012-02-16T21:13:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/</loc>
		<lastmod>2012-02-15T20:39:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/ama-social-media-policy-physicians/</loc>
		<lastmod>2012-02-14T20:44:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/news-events/press-releases/</loc>
		<lastmod>2012-02-10T15:30:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/patient-adherence-teams-organizational-chart/</loc>
		<lastmod>2012-02-10T15:26:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/clinical-msl-move/</loc>
		<lastmod>2012-02-10T03:15:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/medical-affairs-heighten-product/</loc>
		<lastmod>2012-02-10T03:14:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/medical-affairs-thought-leader-relationships/</loc>
		<lastmod>2012-02-10T03:14:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/msl-program-insights/by-the-numbers-msl-team-budgets/</loc>
		<lastmod>2012-02-10T03:11:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/msl-program-insights/</loc>
		<lastmod>2012-02-10T03:05:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/msl-program-insights/reimbursement-challenges-increase-importance-hols/</loc>
		<lastmod>2012-02-10T03:01:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/msl-program-insights/msl-performance-measurement-challenge-opportunity/</loc>
		<lastmod>2012-02-10T02:59:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/msl-program-insights/the-ins-outs-msl-territory-sizing/</loc>
		<lastmod>2012-02-10T02:56:48+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/msl-program-insights/the-evolving-role-of-msls-in-sales-support/</loc>
		<lastmod>2012-02-10T02:53:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/msl-program-insights/demonstrating-msl-programs-roi/</loc>
		<lastmod>2012-02-10T02:20:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/msl-program-insights/how-to-compensate-winning-msl-team/</loc>
		<lastmod>2012-02-10T02:19:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/msl-assessment/</loc>
		<lastmod>2012-02-08T22:19:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/secretnew/thanksgiving-potluck-2011/</loc>
		<lastmod>2012-02-08T21:42:12+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/secretnew/halloween-pumpkin-carving/</loc>
		<lastmod>2012-02-08T21:41:14+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/secretnew/</loc>
		<lastmod>2012-02-08T20:17:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/health-outcomes-liaisons-teams-compensation-professional-development-benchmarks/</loc>
		<lastmod>2012-02-08T16:24:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/</loc>
		<lastmod>2012-02-03T16:27:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/site-map/</loc>
		<lastmod>2012-02-03T16:22:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/thank-you/</loc>
		<lastmod>2012-02-03T15:50:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/about/</loc>
		<lastmod>2012-02-03T15:37:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/about/privacy-policy/</loc>
		<lastmod>2012-02-03T15:29:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/copyright/</loc>
		<lastmod>2012-02-03T15:25:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/extended-sunshine-act-deadline-track-physician-payments/</loc>
		<lastmod>2012-01-31T09:30:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/sunshine-act-kol-relationships/</loc>
		<lastmod>2012-01-30T22:03:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/publications-teams-medical-journal-selection/</loc>
		<lastmod>2012-01-25T17:59:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/kol-payments-drop-by-50-percent/</loc>
		<lastmod>2012-01-25T17:01:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/diabetes-forecast-study-drugs-classes/</loc>
		<lastmod>2012-01-25T16:57:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/investigator-initiated-trials-medical-publications/</loc>
		<lastmod>2012-01-25T16:55:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/physicians-conflict-interest-spotlight-bmj-study-published/</loc>
		<lastmod>2012-01-25T16:52:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/guiding-fda-guidance-biosimilars/</loc>
		<lastmod>2012-01-25T16:29:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/eisai-opens-new-site-in-rtp/</loc>
		<lastmod>2012-01-24T19:49:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/how-do-your-msl-performance-measurements-stack-up/</loc>
		<lastmod>2012-01-24T19:46:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/90-of-companies-now-have-a-dedicated-msl-team/</loc>
		<lastmod>2012-01-24T19:43:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/cei-releases-best-practices-in-msl-team-management-study/</loc>
		<lastmod>2012-01-24T19:41:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/reports/webinars/generic-competition-get-a-head-start/</loc>
		<lastmod>2012-01-24T19:36:55+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pharmaceutical-pricing-team-budgets-outsource-90-spend/</loc>
		<lastmod>2012-01-24T19:35:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/the-earlier-the-better-when-combating-generics/</loc>
		<lastmod>2012-01-24T19:34:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/marketing-patent-cliff/</loc>
		<lastmod>2012-01-24T19:33:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/marketing-lipitor-ad/</loc>
		<lastmod>2012-01-24T19:32:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/youre-invited-to-our-august-webinar-protect-your-brand-now/</loc>
		<lastmod>2012-01-24T19:28:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/portfolio-managers-think-10-years-ahead/</loc>
		<lastmod>2012-01-24T19:24:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/marketing-counter-generic-strategies/</loc>
		<lastmod>2012-01-24T19:22:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/counter-generics-strategies-to-defend/</loc>
		<lastmod>2012-01-24T19:19:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/upcoming-webinar-breaks-down-latest/</loc>
		<lastmod>2012-01-24T19:16:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/breaking-news-roche-files-new-herceptin-combo-with-fda/</loc>
		<lastmod>2012-01-24T19:13:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/drug-companies-need-counter-generics/</loc>
		<lastmod>2012-01-24T19:10:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/new-doors-opening-for-biosimilars/</loc>
		<lastmod>2012-01-24T19:08:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/generic-competition-moving-in-quick/</loc>
		<lastmod>2012-01-24T19:05:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/counter-generics-task-forces-deployed/</loc>
		<lastmod>2012-01-24T19:03:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/why-running-a-tight-counter-generics-task-force-can-save-you-millions/</loc>
		<lastmod>2012-01-24T19:01:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/marketing-diversification/</loc>
		<lastmod>2012-01-24T19:01:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pharmalot-spotlight-on-our-counter-generics-research/</loc>
		<lastmod>2012-01-24T18:59:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/the-importance-of-changing-up-your-generics-defense-strategies/</loc>
		<lastmod>2012-01-24T18:57:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/out-next-week-clinical-trials-patient-recruitment-data/</loc>
		<lastmod>2012-01-24T18:44:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/cost-cutting-clinical-investigator-payments/</loc>
		<lastmod>2012-01-03T19:52:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/investigator-initiated-trial-budgets-rise/</loc>
		<lastmod>2012-01-03T19:14:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/investigator-initiated-trials-formal-management/</loc>
		<lastmod>2012-01-03T18:56:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/physician-salary-data-longer-reliable-practice-calculating-fmv/</loc>
		<lastmod>2012-01-02T21:21:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/travel-costs-key-opinion-leaders-microscope/</loc>
		<lastmod>2012-01-02T21:12:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/country-level-medical-affairs-budgets/</loc>
		<lastmod>2011-12-30T19:42:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/pfizer-aims-to-retain-lipitor-patients/</loc>
		<lastmod>2011-12-30T19:16:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2012/succession-plan-performance-measurements/</loc>
		<lastmod>2011-12-30T18:38:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/succession-planning-at-a-glance/</loc>
		<lastmod>2011-12-30T18:21:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/emerging-markets-pharma-growth-opportunities-patient-challenges/</loc>
		<lastmod>2011-12-21T16:37:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/patient-adherence-tactics-strategies-survey/</loc>
		<lastmod>2011-12-20T20:47:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/top-launch-countries-for-new-drugs/</loc>
		<lastmod>2011-12-13T21:52:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/embrace-comparative-effectiveness-research/</loc>
		<lastmod>2011-12-13T21:52:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/line-extension-tactics-counter-generics-strategy/</loc>
		<lastmod>2011-12-08T21:52:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/clinical-marketing-communication/</loc>
		<lastmod>2011-12-08T21:25:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/new-oncology-forecast-study/</loc>
		<lastmod>2011-12-08T19:54:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/provider-support-programs-roi/</loc>
		<lastmod>2011-12-05T20:30:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/fmv-calculations-preliminary-work-travel/</loc>
		<lastmod>2011-12-05T20:28:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/medical-affairs-performance-measures/</loc>
		<lastmod>2011-12-05T20:26:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/investigator-initiated-trial-internet-submission/</loc>
		<lastmod>2011-12-05T20:06:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/clinical-development-russia-local-registration/</loc>
		<lastmod>2011-12-05T19:58:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/outsourcing-phase-ii-drug-development/</loc>
		<lastmod>2011-12-05T19:49:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pricing-teams-get-more-ftes-and-dollars/</loc>
		<lastmod>2011-12-05T19:34:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/patient-reported-outcomes-budgets/</loc>
		<lastmod>2011-12-01T04:39:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/msl-performance-measurement-opportunities/</loc>
		<lastmod>2011-11-29T21:30:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pharmaceutical-emerging-markets-misconceptions/</loc>
		<lastmod>2011-11-29T21:01:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/clinical-development-newsletter/</loc>
		<lastmod>2011-11-29T19:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/clinical-outsourcing-costs-challenge/</loc>
		<lastmod>2011-11-29T19:17:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/health-economics-spending-increases/</loc>
		<lastmod>2011-11-29T17:36:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/drug-companies-embrace-proactive-approach/</loc>
		<lastmod>2011-11-29T16:34:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/clinical-development-asia-presents-frontier/</loc>
		<lastmod>2011-11-29T15:54:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/dtc-advertising-booming-emerging-markets/</loc>
		<lastmod>2011-11-29T15:28:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/patient-adherence-disease-education-pharmaceutical-marketing-budgets/</loc>
		<lastmod>2011-11-29T15:19:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/emerging-markets-marketing-performance-metrics/</loc>
		<lastmod>2011-11-29T15:17:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/phase-iv-trials-regionalized-differences-regulatory-payer/</loc>
		<lastmod>2011-11-29T14:09:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/drug-device-companies-waiting-sunshine-act-guidelines/</loc>
		<lastmod>2011-11-28T15:16:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/top-performing-lifecycle-management-strategies/</loc>
		<lastmod>2011-11-28T14:41:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/europe-austerity-public-policy-prevent-price-cuts/</loc>
		<lastmod>2011-11-22T21:52:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/medical-affairs-bundle-kol-fmv-series/</loc>
		<lastmod>2011-11-21T20:27:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/h1n1-crisis-could-lead-regulatory-efficiencies/</loc>
		<lastmod>2011-11-18T14:16:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/clinical-trials-emerging-markets-hq-communication/</loc>
		<lastmod>2011-11-16T21:32:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pharma-pricing-guidelines-india/</loc>
		<lastmod>2011-11-16T14:30:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/counter-generic-strategy-series/</loc>
		<lastmod>2011-11-04T19:00:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/mobile-pharma-clinical-development/</loc>
		<lastmod>2011-11-02T18:44:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/phase-4-trials-internal-competition/</loc>
		<lastmod>2011-11-01T21:07:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/outsourcing-health-economics-studies/</loc>
		<lastmod>2011-11-01T19:07:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/services/benchmarking/physician-fair-market-value/</loc>
		<lastmod>2011-10-27T18:53:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/bill-negotiation-medicare-drug-prices/</loc>
		<lastmod>2011-10-21T19:56:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pharmaceutical-sales-management-ratios/</loc>
		<lastmod>2011-10-19T20:29:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/process/success/</loc>
		<lastmod>2011-10-18T13:26:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pediatric-exclusivity-brand-defense/</loc>
		<lastmod>2011-10-13T11:33:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/roadmap-health-outcomes-liaison-career/</loc>
		<lastmod>2011-10-12T16:46:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pharma-self-regulate-digital-marketing/</loc>
		<lastmod>2011-10-11T15:08:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/making-sense-of-social-media-in-regulatory-vacuum/</loc>
		<lastmod>2011-10-11T15:05:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/phase-iv-clinical-trials-outsourcing/</loc>
		<lastmod>2011-10-07T15:38:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/clinical-recruitment-success/</loc>
		<lastmod>2011-10-06T20:18:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/msls-different-sales-reps/</loc>
		<lastmod>2011-10-06T20:10:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pharmaceutical-specialty-sales-forces-expansion/</loc>
		<lastmod>2011-10-06T15:12:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/market-access-budgets-payer-outcomes/</loc>
		<lastmod>2011-10-06T15:11:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/succession-planning-build-academy-company/</loc>
		<lastmod>2011-10-03T19:59:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/succession-planning-talent-retention/</loc>
		<lastmod>2011-09-29T15:59:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/africa%e2%80%99s-potential-clinical-trials/</loc>
		<lastmod>2011-09-29T15:58:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/secret-succession-planning-talent-bench/</loc>
		<lastmod>2011-09-29T15:56:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/plan-2012/</loc>
		<lastmod>2011-09-28T13:41:30+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/thankyou/</loc>
		<lastmod>2011-09-28T13:12:01+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/portfolio-management-study-revealing-interesting-trends/</loc>
		<lastmod>2011-09-26T16:02:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/phase-iv-budgets-per-patient/</loc>
		<lastmod>2011-09-22T21:09:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pharmaceutical-brand-defense-patent-litigation/</loc>
		<lastmod>2011-09-22T13:10:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/technology-patient-adherence/</loc>
		<lastmod>2011-09-20T19:18:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/investigator-initiated-trials-fmv/</loc>
		<lastmod>2011-09-20T19:16:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/market-access-budgets-jump-emerging-markets/</loc>
		<lastmod>2011-09-20T19:15:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/health-economics-outcomes-research-roi/</loc>
		<lastmod>2011-09-20T18:19:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/lipitor-patent-expiration-movement-statin-market/</loc>
		<lastmod>2011-09-20T14:50:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/investigator-initiated-trial-budgets-up/</loc>
		<lastmod>2011-09-13T13:50:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/investigator-initiated-trials-phase-iv-studies/</loc>
		<lastmod>2011-09-12T19:35:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/internal-cros-bring-outsourcing-in-house/</loc>
		<lastmod>2011-09-12T15:43:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/defense-against-the-patent-cliff/</loc>
		<lastmod>2011-09-09T21:26:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/patient-recruitment-funding/</loc>
		<lastmod>2011-09-09T21:19:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/phase-iv-investigator-initiated-trials-preferred-over-phase-iii/</loc>
		<lastmod>2011-09-01T20:17:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/cure-rising-clinical-trial-costs/</loc>
		<lastmod>2011-09-01T20:14:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/drug-companies-in-licensing-deals-accelerate-development-timelines/</loc>
		<lastmod>2011-09-01T20:11:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pricing-activities-support-innovative-pharmaceutical/</loc>
		<lastmod>2011-09-01T20:09:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/flat-fee-most-common-kol-compensation-method-europe/</loc>
		<lastmod>2011-09-01T20:02:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/510k-process-changes-looming/</loc>
		<lastmod>2011-09-01T20:01:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/average-cost-comparative-effectiveness-research-phase-iv/</loc>
		<lastmod>2011-09-01T20:00:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/medical-science-liaisons-go-by-many-titles/</loc>
		<lastmod>2011-09-01T19:59:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/global-compensation-data-physician-fee-schedule-strategies/</loc>
		<lastmod>2011-09-01T19:52:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/risk-taking-agreements/</loc>
		<lastmod>2011-09-01T19:49:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/fda-readies-generics-user-fee-agreement/</loc>
		<lastmod>2011-09-01T19:48:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/open-communication-payers-clinical-development/</loc>
		<lastmod>2011-09-01T19:47:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/market-access-budgets-jump/</loc>
		<lastmod>2011-09-01T15:57:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/patient-recruitment-clinical-vendor-fees-top-trial-cost-drivers/</loc>
		<lastmod>2011-08-30T19:14:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/sneak-preview-msl-best-practices-report-launches-next-week/</loc>
		<lastmod>2011-08-30T18:59:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/pharmaceutical-companies-rebrand-speaker-programs/</loc>
		<lastmod>2011-08-30T18:56:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/greater-communication-between-drug-companies/</loc>
		<lastmod>2011-08-30T18:55:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/pharmaceutical-speaker-programs-medical-education/</loc>
		<lastmod>2011-08-30T18:51:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/pharma-companies-navigate-sunshine-act/</loc>
		<lastmod>2011-08-30T18:48:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/ma-drivers-merger-pfizer-wyeth/</loc>
		<lastmod>2011-08-30T18:46:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/for-pharma-online-patients-present/</loc>
		<lastmod>2011-08-30T18:32:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/economy-challenges-clinical-trial-teams/</loc>
		<lastmod>2011-08-30T18:31:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/large-companies-still-looking-for/</loc>
		<lastmod>2011-08-30T18:28:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/speaker-program-recruitment-demands-more/</loc>
		<lastmod>2011-08-30T18:27:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/company-directory/stephanie-swanson/</loc>
		<lastmod>2011-08-30T18:23:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/six-challenges-thought-leader-faces-regulatory/</loc>
		<lastmod>2011-08-30T18:19:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/drug-information-patient-education/</loc>
		<lastmod>2011-08-30T18:19:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/next-week-oncology-clinical-trials-in-emerging-regions-2010/</loc>
		<lastmod>2011-08-30T18:16:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/clinical-globalize-patient-recruitment/</loc>
		<lastmod>2011-08-30T18:12:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/clinical-emerging-markets/</loc>
		<lastmod>2011-08-30T18:10:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/clinical-scrutiny/</loc>
		<lastmod>2011-08-30T18:09:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/clinical-trial-budget/</loc>
		<lastmod>2011-08-30T18:08:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/medical-information-call-centers-outsource/</loc>
		<lastmod>2011-08-30T18:07:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/clinical-obesity-outlook/</loc>
		<lastmod>2011-08-30T18:06:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/medical-affairs-milestones/</loc>
		<lastmod>2011-08-30T18:05:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/thought-leader-payments-fair-market-values/</loc>
		<lastmod>2011-08-30T18:04:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/marketing-patent-challenges/</loc>
		<lastmod>2011-08-30T18:00:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/clinical-drug-safety/</loc>
		<lastmod>2011-08-30T17:59:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/medical-affairs-summit-meeting/</loc>
		<lastmod>2011-08-30T17:58:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/clinical-patient-recruitment/</loc>
		<lastmod>2011-08-30T17:58:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/clinical-outsourcing-grows/</loc>
		<lastmod>2011-08-30T17:57:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/clinical-early-stage-commercialization/</loc>
		<lastmod>2011-08-30T17:57:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/consulting-oncology-msl/</loc>
		<lastmod>2011-08-30T17:56:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/consulting-drug-safety/</loc>
		<lastmod>2011-08-30T17:56:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/medical-affairs-jj/</loc>
		<lastmod>2011-08-30T17:55:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/medical-outsourcing-medical-affairs-activities/</loc>
		<lastmod>2011-08-30T17:55:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/clinical-cro-market/</loc>
		<lastmod>2011-08-30T17:54:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/clinical-pharmacovigilance/</loc>
		<lastmod>2011-08-30T17:54:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/marketing-survey-results/</loc>
		<lastmod>2011-08-30T17:53:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/marketing-health-economics/</loc>
		<lastmod>2011-08-30T17:52:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/medical-affairs-pharmacovigilance/</loc>
		<lastmod>2011-08-30T17:50:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/medical-affairs-fda/</loc>
		<lastmod>2011-08-30T17:50:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/clinical-tempering-expectations-in-emerging-markets/</loc>
		<lastmod>2011-08-30T17:49:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/marketing-competitive-intelligence/</loc>
		<lastmod>2011-08-30T17:48:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/clinical-new-law/</loc>
		<lastmod>2011-08-30T17:48:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/marketing-comparative-effect/</loc>
		<lastmod>2011-08-30T17:47:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/medical-science-liaison-teams-thought-leader-relationships/</loc>
		<lastmod>2011-08-30T17:42:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/the-fastest-growing-therapeutic-class-autoimmune-agents/</loc>
		<lastmod>2011-08-30T17:10:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/cro-communication-ongoing-clinical-developmentchallenge/</loc>
		<lastmod>2011-08-30T17:02:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/how-does-your-patient-recruitment-budget-stack-up/</loc>
		<lastmod>2011-08-30T16:26:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/succession-planning-remains-underutilized/</loc>
		<lastmod>2011-08-30T15:46:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pharma-social-media/</loc>
		<lastmod>2011-08-23T19:56:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2009/overhauls-to-drug-sales-forces/</loc>
		<lastmod>2011-08-19T19:22:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/why-choose-cei/</loc>
		<lastmod>2011-08-12T19:07:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/physician-assistance-topping-roi-pharmaceutical-marketing/</loc>
		<lastmod>2011-08-04T21:08:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/interview-dyer-msl-compliance/</loc>
		<lastmod>2011-08-03T14:08:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/outsource-medical-communications/</loc>
		<lastmod>2011-08-02T12:51:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/defensive-pricing-patent-litigation-counter-generics/</loc>
		<lastmod>2011-08-02T05:42:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/physician-relationships-healthcare-providers/</loc>
		<lastmod>2011-08-01T19:00:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/key-opinion-leader-compensation-growing-complex-europe/</loc>
		<lastmod>2011-08-01T18:45:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/thought-leader-fmv-benchmarking-service-launches/</loc>
		<lastmod>2011-08-01T18:28:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/news-events/blog/</loc>
		<lastmod>2011-08-01T15:29:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/cro-selection-standards-responsibility/</loc>
		<lastmod>2011-08-01T14:52:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/all-pharmaceutical-sales-management-eyes-on-gsk/</loc>
		<lastmod>2011-08-01T14:22:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/blog/</loc>
		<lastmod>2011-07-28T20:40:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/phase-iv-clinical-trials-management-structure/</loc>
		<lastmod>2011-07-28T20:32:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/affiliates-leading-the-way-combating-biosimilars/</loc>
		<lastmod>2011-07-28T18:40:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/phase-iv-challenges/</loc>
		<lastmod>2011-07-28T18:05:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/new-patient-recruitment-study/</loc>
		<lastmod>2011-07-28T14:08:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/the-clock-is-ticking-do-you-need-more-time-to-prolong-brand-life/</loc>
		<lastmod>2011-07-28T12:28:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/manage-your-growing-medical-affairs-department/</loc>
		<lastmod>2011-07-28T12:11:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/market-access-strategy/</loc>
		<lastmod>2011-07-28T12:08:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/comparative-effectiveness-investigator-initiated-trials/</loc>
		<lastmod>2011-07-28T12:08:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/sunshine-act-uncertainty-clinical-development/</loc>
		<lastmod>2011-07-28T12:06:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/clinical-trial-staffing-levels/</loc>
		<lastmod>2011-07-28T12:05:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/congratulations-to-our-friends-at-pharmaphilos/</loc>
		<lastmod>2011-07-28T12:01:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pharma-reps-add-reimbursement/</loc>
		<lastmod>2011-07-28T11:52:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/news-events/</loc>
		<lastmod>2011-07-27T18:41:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/reports/</loc>
		<lastmod>2011-07-27T18:39:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/increasing-health-economics-spending/</loc>
		<lastmod>2011-07-27T18:31:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pharmaceutical-specialty-representatives-detailing-time/</loc>
		<lastmod>2011-07-27T18:29:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/medical-affairs-teams-responsibilities/</loc>
		<lastmod>2011-07-27T16:13:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/company-directory/david-richardson/</loc>
		<lastmod>2011-07-27T15:53:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/annual-thought-leader-compensation-limits/</loc>
		<lastmod>2011-07-27T13:41:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/european-key-opinion-leaders-fmv/</loc>
		<lastmod>2011-07-26T20:53:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/reports/webinars/navigating-in-a-changing-landscape-webinar/</loc>
		<lastmod>2011-07-26T19:04:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/reports/webinars/</loc>
		<lastmod>2011-07-26T19:03:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/reports/white-papers/</loc>
		<lastmod>2011-07-26T18:59:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/services/benchmarking/</loc>
		<lastmod>2011-07-25T13:22:21+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/due-diligence-costs-pharmaceutical-in-licensing-deals/</loc>
		<lastmod>2011-07-22T21:23:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pharma-business-development-teams-focus-strategic-fit-game/</loc>
		<lastmod>2011-07-22T21:21:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/european-physician-payments-limits/</loc>
		<lastmod>2011-07-22T21:11:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/medical-information-teams-customer-knowledge/</loc>
		<lastmod>2011-07-22T21:09:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/msl-field-time-kol-relationships/</loc>
		<lastmod>2011-07-22T20:55:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/annual-asco-meeting-next-week/</loc>
		<lastmod>2011-07-22T20:41:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/research-director-eric-bolesh-will-present-patient-centered-marketing-findings/</loc>
		<lastmod>2011-07-21T19:32:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/cei-teams-up-to-fight-cystic-fibrosis/</loc>
		<lastmod>2011-07-21T19:03:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/medical-affairs-msl-webinar/</loc>
		<lastmod>2011-07-21T18:52:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/focus-areas/regulatory/</loc>
		<lastmod>2011-07-21T13:55:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/clinical-research-asia-shifting-focus-emerging-markets/</loc>
		<lastmod>2011-07-19T20:29:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/emerging-markets-clinical-trials-development-teams-meet-patient-enrollment-challenges/</loc>
		<lastmod>2011-07-15T19:33:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/per-patient-clinical-trial-costs/</loc>
		<lastmod>2011-07-15T19:09:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/research/marketing/</loc>
		<lastmod>2011-07-14T18:04:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/sunshine-act-impacts-promotional-activities/</loc>
		<lastmod>2011-07-12T17:39:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/edetailing-budgets-top-sales-teams/</loc>
		<lastmod>2011-07-12T17:39:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/pharma-market-research-managers-reevaluate/</loc>
		<lastmod>2011-07-11T20:42:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/process/</loc>
		<lastmod>2011-07-07T17:45:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/why-choose-cei/what-makes-cei-special/</loc>
		<lastmod>2011-07-06T20:34:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/about/company-history/</loc>
		<lastmod>2011-07-06T18:41:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/reports/search-for-reports/</loc>
		<lastmod>2011-07-06T17:23:32+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/company-directory/</loc>
		<lastmod>2011-07-06T17:14:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/focus-areas/market-intelligence/</loc>
		<lastmod>2011-07-03T15:20:11+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/research/market-access/</loc>
		<lastmod>2011-07-01T17:46:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/why-choose-cei/what-makes-cei-special/we-are-pharmaceutical-specialists/</loc>
		<lastmod>2011-06-30T21:52:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2009/pharmaceutical-intelligence-leader-cutting-edge/</loc>
		<lastmod>2011-06-30T21:52:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/services/assessment/</loc>
		<lastmod>2011-06-30T20:26:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/msl-assessment/service-solutions/</loc>
		<lastmod>2011-06-30T20:26:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/msl-assessment/details/</loc>
		<lastmod>2011-06-30T20:26:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/msl-assessment/metrics-list/</loc>
		<lastmod>2011-06-30T20:26:19+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/msl-assessment/value-proposition/</loc>
		<lastmod>2011-06-30T20:26:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/services/</loc>
		<lastmod>2011-06-28T12:45:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2009/generics-will-challenge-parkinsons-drug/</loc>
		<lastmod>2011-06-27T21:20:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2009/new-kol-management-studies-provide/</loc>
		<lastmod>2011-06-27T21:19:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/medical-science-liaisons-responsibilities-evolve/</loc>
		<lastmod>2011-06-27T21:06:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/competitive-intelligence-resources-on-the/</loc>
		<lastmod>2011-06-27T21:03:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/bric-countries-present-patient-recruitment/</loc>
		<lastmod>2011-06-27T20:47:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/disclosure-of-physician-payments-highlights/</loc>
		<lastmod>2011-06-27T20:44:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/consistent-lifecycle-management-plans-prove/</loc>
		<lastmod>2011-06-27T20:42:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/case-studies/</loc>
		<lastmod>2011-06-27T20:40:23+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/reports/latest-reports/</loc>
		<lastmod>2011-06-27T20:36:44+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/global-medical-affairs-strategy-looks-to-local-expertise-for-implementation/</loc>
		<lastmod>2011-06-27T19:26:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/msl-program-opportunities-in-2011/</loc>
		<lastmod>2011-06-27T19:13:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/new-boston-office-offers-rapid/</loc>
		<lastmod>2011-06-27T19:05:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/central-eastern-europe-building-clinical-trial-success/</loc>
		<lastmod>2011-06-27T18:54:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/clinical-development-expands-africas-emerging-markets/</loc>
		<lastmod>2011-06-27T18:15:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pharmas-specialty-hospital-sales-forces-target-10-20-percent-growth/</loc>
		<lastmod>2011-06-27T18:13:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/clinical-development-latin-america-speeding-trial-success/</loc>
		<lastmod>2011-06-27T18:13:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/adaptive-clinical-design/</loc>
		<lastmod>2011-06-27T18:13:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/services/turn-key-pharma-analytics/</loc>
		<lastmod>2011-06-26T22:30:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/services/market-research/</loc>
		<lastmod>2011-06-26T21:55:16+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/research/</loc>
		<lastmod>2011-06-25T20:44:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/reports/surveys/</loc>
		<lastmod>2011-06-24T20:38:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/medical-affairs-msl-webinar-wrap-up/</loc>
		<lastmod>2011-06-24T20:11:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/key-worry-in-outsourcing-is/</loc>
		<lastmod>2011-06-24T19:42:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/cutting-edge-information-ceo-foresees/</loc>
		<lastmod>2011-06-24T19:04:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/cutting-edge-information-uncovers-major/</loc>
		<lastmod>2011-06-24T18:52:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/webinar-addresses-key-drivers-for/</loc>
		<lastmod>2011-06-24T15:03:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/transparency-could-hamper-thought-leader/</loc>
		<lastmod>2011-06-24T15:00:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/cutting-edge-informations-research-to/</loc>
		<lastmod>2011-06-24T14:49:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/reports/webinars/decoding-clinical-operations/</loc>
		<lastmod>2011-06-24T14:15:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/focus-areas/medical-affairs/</loc>
		<lastmod>2011-06-23T18:21:06+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/reports/webinars/implementing-global-fmv-compensation-plan/</loc>
		<lastmod>2011-06-23T16:11:29+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/news-events/cei-in-the-news/</loc>
		<lastmod>2011-06-23T15:58:22+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/news-events/upcoming-events/</loc>
		<lastmod>2011-06-23T15:38:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/reports/webinars/msl-competition-ahead-of-curve/</loc>
		<lastmod>2011-06-23T15:36:37+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/reports/webinars/medical-liaison-program-excellence/</loc>
		<lastmod>2011-06-23T15:34:18+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/why-choose-cei/vs-doing-it-yourself/</loc>
		<lastmod>2011-06-23T15:28:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/why-choose-cei/vs-doing-without/</loc>
		<lastmod>2011-06-23T15:27:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/why-choose-cei/what-makes-cei-special/why-cei-for-pharma-reports/</loc>
		<lastmod>2011-06-23T15:25:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/why-choose-cei/what-makes-cei-special/testimonials/</loc>
		<lastmod>2011-06-23T13:52:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/detailing-rates-increase-20-pharmaceutical-sales-reps/</loc>
		<lastmod>2011-06-22T15:28:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/why-choose-cei/what-makes-cei-special/we-set-the-standard-for-primary-research/</loc>
		<lastmod>2011-06-22T14:19:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/why-choose-cei/what-makes-cei-special/cei%e2%80%99s-strong-experienced-research-team/</loc>
		<lastmod>2011-06-22T14:16:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/why-choose-cei/what-makes-cei-special/can-you-call-your-competitors-we-can/</loc>
		<lastmod>2011-06-22T13:53:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/company-directory/elio-evangelista/</loc>
		<lastmod>2011-06-22T13:42:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/company-directory/adam-bianchi/</loc>
		<lastmod>2011-06-22T13:41:09+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/company-directory/eric-bolesh/</loc>
		<lastmod>2011-06-22T13:40:59+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/company-directory/jason-richardson/</loc>
		<lastmod>2011-06-22T13:39:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/company-directory/jan-blanchette/</loc>
		<lastmod>2011-06-22T13:32:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/company-directory/yanis-saradjian/</loc>
		<lastmod>2011-06-22T13:31:04+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/company-directory/chris-inks/</loc>
		<lastmod>2011-06-22T13:17:15+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/company-directory/jon-hess/</loc>
		<lastmod>2011-06-22T13:16:34+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/company-directory/lenny-donnenfeld/</loc>
		<lastmod>2011-06-22T13:13:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/successful-m-a-integration/</loc>
		<lastmod>2011-06-21T20:18:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/measuring-drug-safety-roi-is/</loc>
		<lastmod>2011-06-21T20:04:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/successful-medical-science-liaison-compensation/</loc>
		<lastmod>2011-06-21T19:59:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/successful-clinical-development-strategies-in/</loc>
		<lastmod>2011-06-21T19:11:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/cutting-edge-informations-president-opens/</loc>
		<lastmod>2011-06-21T18:51:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/health-economics-in-emerging-markets/</loc>
		<lastmod>2011-06-21T18:38:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2009/reimbursement-landscape-demands-health-outcomes/</loc>
		<lastmod>2011-06-21T18:09:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/patient-recruitment-likely-to-benefit/</loc>
		<lastmod>2011-06-21T16:29:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/msl-performance-measurement-an-ongoing/</loc>
		<lastmod>2011-06-21T16:23:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/patient-recruitment-demographics-help-drive/</loc>
		<lastmod>2011-06-21T16:13:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/specialty-and-hospital-sales-forces/</loc>
		<lastmod>2011-06-21T14:59:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/net-present-top-priority-pharmaceutical-in-licensing-deals/</loc>
		<lastmod>2011-06-21T14:58:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/drug-safety-teams-opening-lines/</loc>
		<lastmod>2011-06-21T14:56:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2009/newest-therapeutic-area-study-examines/</loc>
		<lastmod>2011-06-21T14:41:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/drug-safety-outsourcing-requires-careful/</loc>
		<lastmod>2011-06-21T14:14:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/outsourcing-of-medical-information-call/</loc>
		<lastmod>2011-06-21T14:08:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/drug-safety-budgets-must-be/</loc>
		<lastmod>2011-06-21T14:04:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/increase-kol-communication-to-lessen/</loc>
		<lastmod>2011-06-21T13:40:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/antidiabetic-market-to-grow-70/</loc>
		<lastmod>2011-06-21T13:26:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/what-is-the-real-definition/</loc>
		<lastmod>2011-06-20T21:16:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/patient-communication-roi-is-major/</loc>
		<lastmod>2011-06-20T21:06:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2009/clinical-outsourcing-strong-in-recession/</loc>
		<lastmod>2011-06-20T21:04:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/open-invitation-cutting-edge-information/</loc>
		<lastmod>2011-06-20T20:57:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2009/new-study-shows-msls-strategic/</loc>
		<lastmod>2011-06-20T20:55:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2009/outsourcing-a-rarity-for-medical/</loc>
		<lastmod>2011-06-20T20:42:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/regulatory-affairs-budgets-ramp-up/</loc>
		<lastmod>2011-06-20T19:28:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/starting-wednesday-emerging-markets-key-findings-revealed/</loc>
		<lastmod>2011-06-20T19:23:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/spring-msl-webinar-presentation-available-now/</loc>
		<lastmod>2011-06-20T19:16:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/drug-companies-increase-interactions-between/</loc>
		<lastmod>2011-06-20T19:13:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/pharmacoeconomics-to-get-bigger-budgets/</loc>
		<lastmod>2011-06-20T19:09:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/medical-affairs-responsibilities-continue-expand-budgets-shift-global-focus/</loc>
		<lastmod>2011-06-20T18:41:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/competitive-intelligence-groups-most-effective-on-own/</loc>
		<lastmod>2011-06-20T18:20:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/key-opinion-leader-compensation-creates-opportunity/</loc>
		<lastmod>2011-06-20T17:58:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/case-studies/case-study-1-marketing-capabilities/</loc>
		<lastmod>2011-06-13T15:51:31+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/focus-areas/clinical-development/</loc>
		<lastmod>2011-06-13T15:36:51+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/case-studies/case-study-2-clinical-operations/</loc>
		<lastmod>2011-06-08T17:33:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/reports/download-pdf-of-all-reports/</loc>
		<lastmod>2011-06-08T17:20:17+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/focus-areas/</loc>
		<lastmod>2011-06-08T17:11:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/focus-areas/corporate-operations/</loc>
		<lastmod>2011-06-08T17:07:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/focus-areas/market-access/</loc>
		<lastmod>2011-06-08T17:03:45+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/focus-areas/marketing/</loc>
		<lastmod>2011-06-08T17:03:39+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/research/sales/</loc>
		<lastmod>2011-06-08T16:53:58+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/research/regulatory/</loc>
		<lastmod>2011-06-08T16:51:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/research/medical-affairs/</loc>
		<lastmod>2011-06-08T16:46:40+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/research/market-intelligence/</loc>
		<lastmod>2011-06-08T16:46:08+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/research/portfolio-management/</loc>
		<lastmod>2011-06-08T16:42:56+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/focus-areas/portfolio-management/</loc>
		<lastmod>2011-06-07T18:49:20+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/focus-areas/sales/</loc>
		<lastmod>2011-06-07T17:59:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/services/methodology/</loc>
		<lastmod>2011-06-07T15:04:07+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/services/customized-surveys/</loc>
		<lastmod>2011-06-07T14:47:38+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/research/clinical-development/</loc>
		<lastmod>2011-06-02T14:09:13+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/search/</loc>
		<lastmod>2011-05-31T22:30:46+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/reports/categories/</loc>
		<lastmod>2011-05-20T18:53:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2011/pharmaceutical-brands-direct-to-consumer/</loc>
		<lastmod>2011-05-18T19:49:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/why-join/</loc>
		<lastmod>2011-05-11T23:40:25+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/2010/research-from-cutting-edge-information/</loc>
		<lastmod>2011-05-10T17:34:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/what-sets-our-services-apart/save-time-money-and-headaches/</loc>
		<lastmod>2011-05-09T19:31:41+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/what-sets-our-services-apart/</loc>
		<lastmod>2011-05-09T19:18:52+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/reports/what-sets-our-reports-apart/</loc>
		<lastmod>2011-05-09T19:17:57+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/why-choose-cei/the-bottom-line/</loc>
		<lastmod>2011-05-09T19:17:33+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/why-choose-cei/what-makes-cei-special/why-cei-for-pharmaceutical-consulting/</loc>
		<lastmod>2011-05-09T19:16:03+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/why-choose-cei/vs-a-competitor/</loc>
		<lastmod>2011-05-09T19:11:43+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/case-studies/case-study-4-msl-program-structure/</loc>
		<lastmod>2011-04-14T19:55:24+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/case-studies/case-study-3-iis-operations/</loc>
		<lastmod>2011-04-14T19:54:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/contact/form-general-contact/</loc>
		<lastmod>2011-04-08T22:43:00+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/what-sets-our-services-apart/we-start-with-your-needs-in-mind/</loc>
		<lastmod>2011-04-05T16:19:53+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.cuttingedgeinfo.com/consulting/what-sets-our-services-apart/our-consulting-client-list/</loc>
		<lastmod>2011-03-09T18:30:35+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
</urlset>
